Anand Kiran Parikh
President and CEO · Faeth Therapeutics, Inc.
- 2026
- Jul 23, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anand Kiran Parikh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian C. Stephenson - $1.13M in FTH purchases and sales in the last 12 months
- MILLENNIUM MANAGEMENT LLC - $679K in FTH purchases and sales in the last 12 months
- Cambrian BioPharma Inc - $501K in FTH purchases and sales in the last 12 months
- James Peyer - $501K in FTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anand Kiran Parikh?
Anand Kiran Parikh is a corporate insider, tracked as President and CEO of Faeth Therapeutics, Inc. (FTH). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anand Kiran Parikh submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Anand Kiran Parikh been buying or selling stock?
Recorded transactions: 1 open-market purchase ($55K) and 0 open-market sales across all tracked filings.
